Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:59 AM
Ignite Modification Date:
2025-12-25 @ 12:59 AM
NCT ID:
NCT01831193
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of proteinuric chronic kidney disease with 1g or more of proteins in a daily recollection.
* Individuals taking Angiotensin II Receptor Blocker or ACE inhibitors in monotherapy with maximum dose or in combination.
Exclusion Criteria:
* Hepatic damage.
* Malignancy.
* Pregnancy.
* Peritoneal or hemodialysis.
* Organ transplantation.
* Heart failure classification III or IV (New York Heart Association).
* History of chemotherapy within 2 years prior to screening.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT01831193
Study Brief:
Protocol Section:
NCT01831193